Plain-language definitions of the medications, ingredients, hormones, peptides, conditions, and telehealth terms you may encounter at EOS Health and across modern telehealth care. Educational reference only.
A common skin condition in which hair follicles become clogged with oil and dead skin cells, leading to pimples, blackheads, whiteheads, or deeper cysts, most often on the face, chest, and back.
The biologically active component of a medication that produces its intended effect, as distinct from inactive ingredients such as fillers, solvents, or preservatives.
A hereditary, hormone-related form of hair loss that causes gradual thinning of the scalp hair, commonly referred to as male-pattern or female-pattern baldness.
A telehealth model in which a patient submits health information through an online intake form and a licensed clinician reviews it and responds later, without a live real-time appointment.
A compounded topical preparation that combines two estrogens, estriol and estradiol, typically in a 50:50 or 80:20 ratio, used in menopausal hormone therapy.
Hormones that are chemically identical in molecular structure to those naturally produced by the human body, such as estradiol, progesterone, and testosterone. They may be commercially manufactured or compounded.
A synthetic peptide derived from a protein found in gastric juice and studied in research settings. It is not approved by the FDA and is available only through compounding in limited circumstances.
A melanocortin-receptor agonist given by subcutaneous injection and used to address low sexual desire. It is also referred to by the identifier PT-141.
A brand name for the medication tadalafil, a PDE5 inhibitor used for erectile dysfunction. Cialis is a registered trademark of its respective manufacturer.
A synthetic analog of growth-hormone-releasing hormone (GHRH) studied for its effect on growth hormone secretion, frequently paired with ipamorelin. It is not FDA-approved and is available only through compounding.
A medication prepared by a licensed pharmacy for an individual patient by combining, mixing, or altering ingredients. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or manufacturing quality.
A pharmacy licensed to prepare customized medications for individual patients from a prescription, including 503A pharmacies and 503B outsourcing facilities.
A potent androgen hormone derived from testosterone by the enzyme 5-alpha-reductase. It plays a role in androgenetic hair loss and prostate growth.
A condition in which a person is unable to get or keep an erection firm enough for satisfactory sexual activity.
The primary and most potent form of estrogen produced by the ovaries. It is available in forms such as patches, gels, tablets, and vaginal preparations for use in hormone therapy.
A milder form of estrogen often used in compounded topical hormone preparations such as Biest.
A group of sex hormones, including estradiol, estriol, and estrone, that regulate the reproductive system and influence bone, skin, and other tissues.
An oral or topical medication classified as a 5-alpha-reductase inhibitor, used for androgenetic hair loss by lowering levels of dihydrotestosterone (DHT).
A medication that contains the same active ingredient as a brand-name drug and is sold under its chemical name rather than a trademarked brand name.
A naturally occurring copper-binding peptide (copper tripeptide-1) used in topical skin preparations.
A class of medications that mimic the glucagon-like peptide-1 hormone, which is involved in blood-sugar regulation and appetite. Semaglutide and tirzepatide belong to this general class.
A naturally occurring antioxidant made of three amino acids (cysteine, glutamate, and glycine). It is used in injectable and nasal-spray preparations as part of longevity and skin protocols.
A simple amino acid sometimes added to compounded injectable medications as a stabilizing or bulking agent.
A compound that signals the body to produce and release its own growth hormone. Peptides such as sermorelin, CJC-1295, and ipamorelin fall into this category.
The partial or complete loss of hair from the scalp or body. It can be hereditary, hormonal, or triggered by stress, nutrition, or medical conditions.
A U.S. federal law that sets national standards for protecting sensitive patient health information from being disclosed without the patient's consent or knowledge.
Treatment that uses hormones to restore levels that have declined or become imbalanced, prescribed and monitored by a licensed clinician. Also described as hormone therapy.
The use of hormones such as estradiol, progesterone, or testosterone to supplement levels that decline with age or menopause. It is prescribed and monitored by a licensed clinician.
Sudden feelings of warmth, often most intense over the face, neck, and chest, that are a common symptom of perimenopause and menopause.
Darkening of areas of skin caused by excess melanin, which can result from sun exposure, inflammation, or hormonal changes.
Persistently low sexual desire that causes personal distress and is not explained by another medical or psychiatric condition.
A condition in which the body produces little or no sex hormones, such as low testosterone in men, which may affect energy, mood, and libido.
A condition in which the body's cells respond less effectively to insulin, leading to higher blood-sugar levels and often associated with weight gain and metabolic conditions.
A synthetic peptide studied as a growth-hormone secretagogue, often paired with CJC-1295. It is not FDA-approved and is available only through compounding.
A field focused on supporting healthy aging and long-term wellness through preventive care, lifestyle, and clinician-guided protocols.
A decrease in sexual desire that can be influenced by hormones, stress, relationships, medications, or underlying health conditions.
A form of hyperpigmentation that produces brown or gray-brown patches, usually on the face, and is often associated with hormonal changes and sun exposure.
The point at which menstrual periods have stopped for 12 consecutive months, marking the end of reproductive years and a decline in estrogen and progesterone.
A measure of how well the body processes and regulates energy, including blood sugar, cholesterol, blood pressure, and weight.
An active form of vitamin B12, a nutrient involved in energy metabolism and nerve function, sometimes added to injectable compounds.
A combination of the compounds methionine, inositol, and choline, sometimes given with vitamin B12 as part of metabolic support protocols.
A medication available in oral and topical forms used for hair loss. It is a vasodilator that acts on the hair follicle.
A coenzyme found in every living cell that is involved in energy production and cellular metabolism. It is used in injectable and nasal-spray forms as part of longevity protocols.
The practice of a licensed clinician prescribing an approved medication for a purpose, dose, or population other than the one described in its official labeling, based on clinical judgment.
A brand name for the injectable medication semaglutide, a GLP-1 receptor agonist indicated for type 2 diabetes. Ozempic is a registered trademark of its respective manufacturer.
A class of medications, including sildenafil and tadalafil, that relax blood vessels and are used for erectile dysfunction.
A short chain of amino acids, the building blocks of proteins. In medicine, peptides are used as hormones, signaling molecules, and active ingredients in certain therapies.
The use of peptide-based compounds under clinician supervision. Some peptides are FDA-approved medications, while others are research compounds available only through compounding in specific circumstances.
The transitional years leading up to menopause, when hormone levels fluctuate and symptoms such as irregular periods, hot flashes, and mood changes may begin.
An order for a medication written by a licensed clinician. Prescription medications require this authorization before a pharmacy can dispense them.
A hormone produced mainly by the ovaries that helps regulate the menstrual cycle and is used in hormone therapy, often alongside estrogen.
An identifier for the peptide bremelanotide, a melanocortin-receptor agonist administered by injection and used to address low sexual desire.
A vitamin A derivative (also called tretinoin) used in topical skin preparations for acne and signs of skin aging.
A GLP-1 receptor agonist that influences blood-sugar regulation and appetite. It is available as a branded injectable medication and, in some circumstances, as a compounded preparation.
A synthetic analog of growth-hormone-releasing hormone studied for its effect on the body's own growth hormone production. It is prepared through compounding.
A PDE5 inhibitor taken by mouth and used for erectile dysfunction by increasing blood flow.
An injection given into the fatty tissue just beneath the skin, a common route of administration for many self-administered medications.
A route of administration in which a medication is placed under the tongue to dissolve and be absorbed.
A long-acting PDE5 inhibitor taken by mouth and used for erectile dysfunction by increasing blood flow.
The delivery of health care, education, and consultation remotely using technology such as secure messaging, video visits, and online intake forms.
A subset of telehealth focused specifically on remote clinical services, such as diagnosing conditions and prescribing treatment through virtual visits.
A growth-hormone-releasing hormone analog that stimulates the body's production of growth hormone. It is administered by subcutaneous injection.
The primary male sex hormone, also present in smaller amounts in women, that influences muscle mass, bone density, mood, energy, and libido.
Treatment that supplements testosterone in people with clinically low levels, prescribed and monitored by a licensed clinician as part of hormonal balance care.
A peptide that occurs naturally in the thymus gland and is studied for its role in immune signaling. It is available only through compounding in specific circumstances.
A dual GIP and GLP-1 receptor agonist that influences blood-sugar regulation and appetite. It is available as a branded injectable medication and, in some circumstances, as a compounded preparation.
The gradual adjustment of a medication dose, usually increasing over time, to reach the amount that is appropriate for an individual under clinician guidance.
A medication applied directly to the skin or another body surface, such as a cream, gel, lotion, or solution.
A topical vitamin A derivative (retinoic acid) used in skin preparations for acne and signs of aging.
Thinning, drying, and inflammation of the vaginal walls that can occur when estrogen levels decline, often around menopause.
A brand name for the medication sildenafil, a PDE5 inhibitor used for erectile dysfunction. Viagra is a registered trademark of its respective manufacturer.
A brand name for the injectable medication semaglutide, a GLP-1 receptor agonist indicated for chronic weight management. Wegovy is a registered trademark of its respective manufacturer.
A brand name for the injectable medication tirzepatide, a GIP/GLP-1 receptor agonist indicated for chronic weight management. Zepbound is a registered trademark of its respective manufacturer.
No terms match your search.
Educational information only. This glossary is provided for general informational purposes and is not medical advice, a diagnosis, or a treatment recommendation. It does not describe the safety or effectiveness of any specific EOS Health product. Compounded medications are not reviewed by the FDA for safety, effectiveness, or manufacturing quality. Always talk with a licensed healthcare provider about your individual health needs. Brand names are the trademarks of their respective owners and are used for identification only.